Igyxos Biotherapeutics Overview

  • Founded
  • 2017

Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $5.32M

  • Investors
  • 8

Igyxos Biotherapeutics General Information

Description

Developer of pharmaceuticals and medical technologies designed to address the growing global need for improved infertility solutions for both men and women. The company specializes in identifying monoclonal antibodies that bind to and enhance the activity of gonadotropins, and hormones involved in effective reproduction, helping patients to significantly improve their activity for fertility treatments.

Contact Information

Website
www.igyxos.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Other Healthcare Services
Biotechnology
Primary Office
  • Centre INRA Val de Loire
  • Site de Tours
  • 37380 Nouzilly
  • France
+33 02 00 00 00 00

Igyxos Biotherapeutics Timeline

2020202120222023
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Igyxos Biotherapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC 24-Jun-2021 $5.32M 000.00 000.00 Completed Clinical Trials - Phase 1
2. Early Stage VC 30-Jun-2020 00.00 000.00 00.000 Completed Clinical Trials - Phase 1
1. Early Stage VC (Series A) 21-Mar-2019 $8.49M $8.49M Completed Pre-Clinical Trials
To view Igyxos Biotherapeutics’s complete valuation and funding history, request access »

Igyxos Biotherapeutics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
A Shares 00,000 00.000000 0000.00 0000.00 00 0000.00 00.000
O Shares 000 00.000000 0000.00 0000.00 0000.00 0.000
A Shares 400 $7.259882 $455.56 $455.56 1x $455.56 1.78%
O Shares 6,579 $7.259882
To view Igyxos Biotherapeutics’s complete cap table history, request access »

Igyxos Biotherapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of pharmaceuticals and medical technologies designed to address the growing global need for improved infertili
Drug Discovery
Nouzilly, France
10 As of 2023
000.00
00.00 0000-00-00
0000000000 0 000.00

000000

quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequ
00000 0000000000 000
Franklin, TN
00 As of 0000
00000
000000000 00000

000000

tetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magn
0000000000 00000000
Woburn, MA
00 As of 0000
000.00
000 0000-00-00
000000&0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Igyxos Biotherapeutics Competitors (8)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Prelude Fertility Private Equity-Backed Franklin, TN 00 00000 000000000 00000
00000000000 Formerly VC-backed Woburn, MA 00 000.00 000000&0 000.00
00000 & 00. Corporation Rahway, NJ 00000 000.00 000000000 000.00
0000000 0000000000 Private Equity-Backed Durham, NC 00000 00000 000000000 00000
00000 000000000000 Formerly VC-backed Princeton, NJ 00 00000 000000000 00000
You’re viewing 5 of 8 competitors. Get the full list »

Igyxos Biotherapeutics Executive Team (3)

Name Title Board Seat Contact Info
Pierre-Henry Longeray Chief Executive Officer, Managing Director & General Manager
Thierry Ziegler Chief Operating Officer
Marie-Christine Maurel Founder, Chief Science Officer, President & Chairman
To view Igyxos Biotherapeutics’s complete executive team members history, request access »

Igyxos Biotherapeutics Board Members (7)

Name Representing Role Since
Benoit Barteau Ph.D Bpifrance Board Member 000 0000
François Miceli Sofimac Innovation Board Member 000 0000
Herve Bachelot Lallier GO Capital (France) Board Member 000 0000
Igor Fisch Igyxos Biotherapeutics Board Member 000 0000
Jessica Zoller Self Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

Igyxos Biotherapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Igyxos Biotherapeutics Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
UI Investissement PE/Buyout Minority 000 0000 000000 0
Apicap PE/Buyout Minority 000 0000 000000 0
Bpifrance Sovereign Wealth Fund Minority 000 0000 000000 0
Centre Capital Développement Venture Capital Minority 000 0000 000000 0
Emergence (Incubation) Asset Manager Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »

Ready to get started?

Request a free trial